• 1
    Matricardi, P. M., Rosmini, F., Ferrigno, L., Nisini, R., Rapicetta, M., Chionne, P., Stroffolini, T., Pasquini, P. and D'Amelio, R., Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997. 314: 9991003.
  • 2
    Matricardi, P. M., Rosmini, F., Riondino, S., Fortini, M., Ferrigno, L., Rapicetta, M. and Bonini, S., Exposure to foodborne and orofecal microbes versus airborne viruses in relationto atopy and allergic asthma: epidemiological study. BMJ 2000. 320: 412417.
  • 3
    Alm, J. S., Swartz, J., Lilja, G., Scheynius, A. and Pershagen, G., Atopy in children of families with an anthroposophic lifestyle. Lancet 1999. 353: 14851488.
  • 4
    Von Ehrenstein, O. S., von Mutius, E., Illi, S., Baumann, L., Bohm, O. and von Kries, R., Reduced risk of hay fever and asthma among children of farmers. Clin. Exp. Allergy 2000. 30: 187193.
  • 5
    The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998. 351: 12251232.
  • 6
    Scrivener, S., Yemaneberhan, H., Zebenigus, M., Tilahun, D., Girma, S., Ali, S., McElroy, P., Custovic, A., Woodcock, A., Pritchard, D., Venn, A. and Britton, J., Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet 2001. 358: 14931499.
  • 7
    Van den Biggelaar, A. H., van Ree, R., Rodrigues, L. C., Lell, B., Deelder, A. M., Kremsner, P. G. and Yazdanbakhsh, M., Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000. 356: 17231727.
  • 8
    Stene, L. C. and Nafstad, P., Relation between occurrence of type 1 diabetes and asthma. Lancet 2001. 357: 607608.
  • 9
    Wills-Karp, M., Santeliz, J. and Karp, C. L., The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat. Rev. Immunol. 2001. 1: 6975.
  • 10
    Yazdanbakhsh, M., Kremsner, P. G. and van Ree, R., Allergy, parasites, and the hygiene hypothesis. Science 2002. 296: 490494.
  • 11
    Braun-Fahrlander, C., Riedler, J., Herz, U., Eder, W., Waser, M., Grize, L., Maisch, S., Carr, D., Gerlach, F., Bufe, A., Lauener, R. P., Schierl, R., Renz, H., Nowak, D. and von Mutius, E., Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 2002. 347: 869877.
  • 12
    Steel, C. and Nutman, T. B., Ctla-4 in filarial infections: implications for a role in diminished T cell reactivity. J. Immunol. 2003. 170: 19301938.
  • 13
    Satoguina, J., Mempel, M., Larbi, J., Badusche, M., Loliger,C., Adjei, O., Gachelin, G., Fleischer, B. and Hoerauf, A., Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes. Infect. 2002. 4: 12911300.
  • 14
    Kilian, H. D. and Nielsen, G., Cell-mediated and humoral immune responses to BCG and rubella vaccinations and to recall antigens in onchocerciasis patients. Trop. Med. Parasitol. 1989. 40: 445453.
  • 15
    Cooper, P. J., Espinel, I., Paredes, W., Guderian, R. H. and Nutman, T. B., Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J. Infect. Dis. 1998. 178: 11331138.
  • 16
    Bashir, M. E., Andersen, P., Fuss, I. J., Shi, H. N. and Nagler-Anderson, C., An enteric helminth infection protects against an allergic response to dietary antigen. J. Immunol. 2002. 169: 32843292.
  • 17
    Zaccone, P., Fehervari, Z., Jones, F. M., Sidobre, S., Kronenberg, M., Dunne, D. W. and Cooke, A., Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol. 2003. 33: 14391449.
  • 18
    Zuany-Amorim, C., Sawicka, E., Manlius, C., Le Moine, A., Brunet, L. R., Kemeny, D. M., Bowen, G., Rook, G. and Walker, C., Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 2002. 8: 625629.
  • 19
    Van der Kleij, D., Latz, E., Brouwers, J. F., Kruize, Y. C., Schmitz, M., Kurt-Jones, E. A., Espevik, T., de Jong, E. C., Kapsenberg, M. L., Golenbock, D. T., Tielens, A. G. and Yazdanbakhsh, M., A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J. Biol.Chem. 2002. 277: 4812248129.
  • 20
    Sala, A. and Folco, G., Neutrophils, endothelial cells, and cysteinyl leukotrienes: a new approach to neutrophil-dependent inflammation? Biochem. Biophys. Res. Commun. 2001. 283: 10031006.
  • 21
    Kilfeather, S., 5-lipoxygenase inhibitors for the treatment of COPD. Chest 2002. 121: 197S–200S.
  • 22
    Rappaport, R. S. and Dodge, G. R., Prostaglandin E inhibits the production of human interleukin 2. J. Exp. Med. 1982. 155: 943948.
  • 23
    Krause, D. S. and Deutsch, C., Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. J. Immunol. 1991. 146: 22852296.
  • 24
    Kunkel, S. L., Chensue, S. W. and Phan, S. H., Prostaglandins as endogenous mediators of interleukin 1 production. J. Immunol. 1986. 136: 186192.
  • 25
    Kunkel, S. L., Wiggins, R. C., Chensue, S. W. and Larrick, J., Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem. Biophys. Res. Commun. 1986. 137: 404410.
  • 26
    van der Pouw Kraan, T. C., Boeije, L. C., Smeenk, R. J., Wijdenes, J. and Aarden, L. A., Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 1995. 181: 775779.
  • 27
    Strassmann, G., Patil-Koota, V., Finkelman, F., Fong, M. and Kambayashi, T., Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp.Med. 1994. 180: 23652370.
  • 28
    Gosset, P., Bureau, F., Angeli, V., Pichavant, M., Faveeuw, C., Tonnel, A. B. and Trottein, F., Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J. Immunol. 2003. 170: 49434952.
  • 29
    Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S. and Nagata, K., Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembranereceptor CRTH2. J. Exp. Med. 2001. 193: 255261.
  • 30
    Pinge-Filho, P., Tadokoro, C. E. and Abrahamsohn, I. A., Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell. Immunol. 1999. 193: 9098.
  • 31
    Angeli, V., Faveeuw, C., Roye, O., Fontaine, J., Teissier, E., Capron, A., Wolowczuk, I., Capron, M. and Trottein, F., Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 2001. 193: 11351147.
  • 32
    Sommer, A., Rickert, R., Fischer, P., Steinhart, H., Walter,R. D. and Liebau, E., A dominant role for extracellular glutathione S-transferase from Onchocerca volvulus is the production of prostaglandin D2. Infect. Immun. 2003. 71: 36033606.
  • 33
    McMahon, B., Mitchell, S., Brady, H. R. and Godson, C., Lipoxins: revelations on resolution. Trends Pharmacol. Sci. 2001. 22: 391395.
  • 34
    Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C. N. and Sher, A., Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 2002. 3:7682.
  • 35
    Aliberti, J., Serhan, C. and Sher, A., Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp.Med. 2002. 196: 12531262.
  • 36
    Bonnans, C., Vachier, I., Chavis, C., Godard, P., Bousquet, J. and Chanez, P., Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am. J. Respir. Crit. Care Med. 2002. 165: 15311535.
  • 37
    Levy, B. D., De Sanctis, G. T., Devchand, P. R., Kim, E., Ackerman, K., Schmidt, B. A., Szczeklik, W., Drazen, J. M. and Serhan, C. N., Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat. Med. 2002. 8: 10181023.
  • 38
    Chiang, N., Fierro, I. M., Gronert, K. and Serhan, C. N., Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 2000. 191: 11971208.
  • 39
    Devchand, P. R., Arita, M., Hong, S., Bannenberg, G., Moussignac, R. L., Gronert, K. and Serhan, C. N., Human ALX receptor regulates neutrophil recruitment in transgenic mice: rolesin inflammation and host defense. FASEB J. 2003. 17: 652659.
  • 40
    Schaldach, C. M., Riby, J. and Bjeldanes, L. F., Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 1999. 38: 75947600.
  • 41
    Lee, H. K., Lee, J. and Tobias, P. S., Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J. Immunol. 2002. 168: 40124017.
  • 42
    Aliprantis, A. O., Yang, R. B., Mark, M. R., Suggett, S., Devaux, B., Radolf, J. D., Klimpel, G. R., Godowski, P. and Zychlinsky, A., Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999. 285: 736739.
  • 43
    Muhlradt, P. F., Kiess, M., Meyer, H., Sussmuth, R. and Jung, G., Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 1997. 185: 19511958.
  • 44
    Takeuchi, O., Kaufmann, A., Grote, K., Kawai, T., Hoshino, K., Morr, M., Muhlradt, P. F. and Akira, S., Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 2000. 164: 554557.
  • 45
    Morath, S., Stadelmaier, A., Geyer, A., Schmidt, R. R. and Hartung, T., Synthetic lipoteichoic acid from Staphylococcus aureus Is a potent stimulus of cytokine release. J. Exp. Med. 2002. 195: 16351640.
  • 46
    Zhang, H., Tay, P. N., Cao, W., Li, W. and Lu, J., Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling. FEBS Lett. 2002. 532: 171176.
  • 47
    Ozinsky, A., Underhill, D. M., Fontenot, J. D., Hajjar, A. M., Smith, K. D., Wilson, C. B., Schroeder, L. and Aderem, A., The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. U S A 2000. 97: 1376613771.
  • 48
    Takeda, K., Takeuchi, O. and Akira, S., Recognition of lipopeptides by Toll-like receptors. J. Endotoxin. Res. 2002. 8: 459463.
  • 49
    Morr, M., Takeuchi, O., Akira, S., Simon, M. M. and Muhlradt, P. F., Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur. J. Immunol. 2002. 32: 33373347.
  • 50
    Schnare, M., Barton, G. M., Holt, A. C., Takeda, K., Akira, S. and Medzhitov, R., Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2001. 2: 947950.
  • 51
    Jankovic, D., Kullberg, M. C., Hieny, S., Caspar, P., Collazo, C. M. and Sher, A., In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting. Immunity 2002. 16: 429439.
  • 52
    Noss, E. H., Pai, R. K., Sellati, T. J., Radolf, J. D., Belisle, J., Golenbock, D. T., Boom, W. H. and Harding, C. V., Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 2001. 167: 910918.
  • 53
    Brodskyn, C., Patricio, J., Oliveira, R., Lobo, L., Arnholdt, A., Mendonca-Previato, L., Barral, A. and Barral-Netto, M., Glycoinositolphospholipids fromTrypanosoma cruzi interfere with macrophages and dendritic cell responses. Infect. Immun. 2002. 70: 37363743.
  • 54
    Campos, M. A., Almeida, I. C., Takeuchi, O., Akira, S., Valente, E. P., Procopio, D. O., Travassos, L. R., Smith, J. A., Golenbock, D. T. and Gazzinelli, R. T., Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol 2001. 167: 416423.
  • 55
    Ponte-Sucre, A., Heise, D. and Moll, H., Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells. Immunology 2001. 104: 462467.
  • 56
    Underhill, D. M., Mini-review: Toll-like receptors: networking for success. Eur. J. Immunol. 2003. 33: 17671775.
  • 57
    Allan, D., Payares, G. and Evans, W. H., The phospholipid and fatty acid composition of Schistosoma mansoni and of its purified tegumental membranes. Mol. Biochem. Parasitol 1987. 23: 123128.
  • 58
    Brouwers, J. F. H. M., Gadella, B. M., van Golde, L. M. and Tielens, A. G., Quantitative analysis of phosphatidylcholine molecular species using HPLC and light scattering detection. J. Lipid Res. 1998. 39: 344353.
  • 59
    Brouwers, J. F. H. M., Van Hellemond, J. J., van Golde, L. M. and Tielens, A. G., Ether lipids and their possible physiological function in adult Schistosoma mansoni. Mol. Biochem. Parasitol 1998. 96: 4958.
  • 60
    Brouwers, J. F. H. M., Versluis, C., van Golde, L. M. and Tielens, A. G., 5-Octadecenoic acid: evidence for a novel type of fatty acid modification in schistosomes. Biochem. J. 1998. 334: 315319.
  • 61
    Brouwers, J. F. H. M., Skelly, P. J., van Golde, L. M. and Tielens, A. G., Studies on phospholipid turnover argue against sloughing of tegumental membranes in adult Schistosoma mansoni. Parasitology 1999. 119: 287294.
  • 62
    Golan, D. E., Brown, C. S., Cianci, C. M., Furlong, S. T. and Caulfield, J. P., Schistosomula of Schistosoma mansoni use lysophosphatidylcholine to lyse adherent human red blood cells and immobilize red cell membrane components. J. Cell Biol. 1986. 103: 819828.
  • 63
    Furlong, S. T. and Caulfield, J. P., Schistosoma mansoni: synthesis and release of phospholipids, lysophospholipids, and neutral lipids by schistosomula. Exp. Parasitol. 1989. 69: 6577.
  • 64
    Lochnit, G., Dennis, R. D., Ulmer, A. J. and Geyer, R., Structural elucidation and monokine-inducing activity of two biologically active zwitterionic glycosphingolipids derived from the porcine parasitic nematode Ascaris suum. J. Biol. Chem. 1998. 273: 466474.
  • 65
    Van der Kleij, D., van Remoortere, A., Schuitemaker, J. H., Kapsenberg, M. L., Deelder, A. M., Tielens, A. G., Hokke, C. H. and Yazdanbakhsh, M., Triggerng of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GalNAc beta 1–4(Fuc alpha 1–2Fuc alpha 1–3)GlcNAc. J. Infect. Dis. 2002. 185: 531539.
  • 66
    Brouwers, J. F. H. M., Smeenk, I. M., van Golde, L. M. and Tielens, A. G., The incorporation, modification and turnover of fatty acids in adult Schistosoma mansoni. Mol. Biochem. Parasitol. 1997. 88: 175185.
  • 67
    Wuhrer, M., Dennis, R. D., Doenhoff, M. J. and Geyer, R., Stage-associated expression of ceramide structures in glycosphingolipids from the human trematode parasite Schistosoma mansoni. Biochim. Biophys. Acta 2000. 1524: 155161.
  • 68
    Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. and Glass, C. K., The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998. 391: 7982.
  • 69
    Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C. H., Sengchanthalangsy, L. L., Ghosh, G. and Glass, C. K., 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl. Acad. Sci. USA 2000. 97: 48444849.
  • 70
    Ward, C., Dransfield, I., Murray, J., Farrow, S. N., Haslett, C. and Rossi, A. G., Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappaB alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. J. Immunol. 2002. 168: 62326243.
  • 71
    Nencioni, A., Lauber, K., Grunebach, F., Brugger, W., Denzlinger, C., Wesselborg, S. and Brossart, P., Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli. Exp. Hematol. 2002. 30: 10201028.
  • 72
    Clark, R. B., The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 2002. 71: 388400.
  • 73
    Cippitelli, M., Fionda, C., Di Bona, D., Lupo, A., Piccoli, M., Frati, L. and Santoni, A., The cyclopentenone-type prostaglandin 15-deoxy-delta12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms. J. Immunol. 2003. 170: 45784592.
  • 74
    Kawahito, Y., Kondo, M., Tsubouchi, Y., Hashiramoto, A., Bishop-Bailey, D., Inoue, K., Kohno, M., Yamada, R., Hla, T. and Sano, H., 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J. Clin. Invest 2000. 106: 189197.
  • 75
    Lawrence, T., Willoughby, D. A. and Gilroy, D. W., Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2002. 2: 787795.
  • 76
    Diab, A., Deng, C., Smith, J. D., Hussain, R. Z., Phanavanh,B., Lovett-Racke, A. E., Drew, P. D. and Racke, M. K., Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 2002. 168: 25082515.
  • 77
    Hla, T., Lee, M. J., Ancellin, N., Paik, J. H. and Kluk, M. J., Lysophospholipids–receptor revelations. Science 2001. 294: 18751878.
  • 78
    Graler, M. H. and Goetzl, E. J., Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim. Biophys. Acta 2002. 1582: 168174.
  • 79
    Panther, E., Idzko, M., Corinti, S., Ferrari, D., Herouy, Y., Mockenhaupt, M., Dichmann, S., Gebicke-Haerter, P., Di Virgilio, F., Girolomoni, G. and Norgauer, J., The influence of lysophosphatidic acid on the functions of human dendritic cells. J. Immunol. 2002. 169: 41294135.
  • 80
    Idzko, M., Panther, E., Corinti, S., Morelli, A., Ferrari, D., Herouy, Y., Dichmann, S., Mockenhaupt, M., Gebicke-Haerter, P., Di Virgilio, F., Girolomoni, G. and Norgauer, J., Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J. 2002. 16: 625627.
  • 81
    Chilton, F. H., Averill, F. J., Hubbard, W. C., Fonteh, A. N., Triggiani, M. and Liu, M. C., Antigen-induced generation of lyso-phospholipids in human airways. J. Exp. Med. 1996. 183: 22352245.
  • 82
    Toews, M. L., Ediger, T. L., Romberger, D. J. and Rennard, S. I., Lysophosphatidic acid in airway function and disease. Biochim. Biophys. Acta 2002. 1582: 240250.
  • 83
    Coutant, F., Perrin-Cocon, L., Agaugue, S., Delair, T., Andre, P. and Lotteau, V., Mature dendritic cell generation promoted by lysophosphatidylcholine. J. Immunol. 2002. 169: 16881695.
  • 84
    Le, L. Q., Kabarowski, J. H., Weng, Z., Satterthwaite, A. B., Harvill, E. T., Jensen, E. R., Miller, J. F. and Witte, O. N., Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 2001. 14: 561571.
  • 85
    Savill, J. and Fadok, V., Corpse clearance defines the meaning of cell death. Nature 2000. 407: 784788.
  • 86
    Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A. and Henson, P. M., A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000. 405: 8590.
  • 87
    Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y. and Henson, P. M., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest 1998. 101: 890898.
  • 88
    Urban, B. C., Willcox, N. and Roberts, D. J., A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. U S A 2001. 98: 87508755.
  • 89
    Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S. and Bhardwaj, N., Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000. 191: 423434.
  • 90
    Steinman, R. M., Turley, S., Mellman, I. and Inaba, K., The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 2000. 191: 411416.
  • 91
    Jenson, J. S., O'Connor, R., Osborne, J. and Devaney, E., Infection with Brugia microfilariae induces apoptosis of CD4(+) T lymphocytes: a mechanism of immune unresponsiveness in filariasis. Eur. J. Immunol. 2002. 32: 858867.
  • 92
    Semnani, R. T., Liu, A. Y., Sabzevari, H., Kubofcik, J., Zhou, J., Gilden, J. K. and Nutman, T. B., Brugia malayi microfilariae induce cell death in human dendritic cells, inhibit their ability to make IL-12 and IL-10, and reduce their capacity to activate CD4+ T cells. J. Immunol. 2003. 171: 19501960.